---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-031266"
form_type: "8-K"
ticker: "STXS"
cik: "0001289340"
company_name: "Stereotaxis, Inc."
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T09:58:34.816126+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Stereotaxis Q2 revenue down 43% to $4.5M; net loss $5.8M; expects H2 revenue >$14M

## Summary
- Q2 revenue $4.5M vs $7.9M prior year; system revenue $0.2M due to hospital construction delays.
- Net loss $5.8M, adjusted net loss $3.3M; operating loss $6.0M, adjusted $3.5M.
- Cash and cash equivalents $15.2M at June 30, 2024, no debt; year-end cash target ~$13M.
- CE mark obtained for GenesisX, 510(k) submitted in US; acquisition of Access Point Technologies closed.
- Full-year revenue expected approximately equal to prior year; H2 revenue >$14M from stable recurring and Genesis shipments.

## SEC filing metadata
- accession: 0001493152-24-031266
- form_type: 8-K
- ticker: STXS
- cik: 0001289340
- company_name: Stereotaxis, Inc.
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289340/000149315224031266/0001493152-24-031266-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289340/000149315224031266/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-031266
- JSON: https://secwatch.observer/filing/0001493152-24-031266.json
- Plain text: https://secwatch.observer/filing/0001493152-24-031266.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.